UVA Licensing &a; Ventures Group is an investment firm.
Business Model: Education
Revenue: $2.9B
Employees: 10,001-999,999
Address: 1450 Leake Drive
City: Charlottesville
State: VA
Zip: 22904
Country: US
University of Virginia is a Virginia-based educational institution that offers undergraduate and graduate programs in disciplines such as history, English and philosophy.
Contact Phone:
+14349820258
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | NANOCHON | Seed Round | 0 |
7/2016 | TypeZero Technologies | Seed Round | - |
12/2022 | Utrain Inc. | Grant | 20k |
8/2020 | BrightSpec | Series B | - |
12/2022 | BrightSpec | Series C | 18.4M |
5/2018 | 510 Kardiac Devices | Seed Round | - |
10/2018 | Mission Secure | Series A | 0 |
1/2017 | TearSolutions | Venture Round | - |
6/2019 | Direct Spinal Therapeutics | Venture Round | - |
1/2021 | Mission Secure | Series B | 0 |
1/2021 | Slate Bio | Seed Round | 0 |
7/2019 | Merand Pharmaceuticals | Seed Round | - |
5/2019 | Arrive Health (formerly RxRevu) | Series A | 0 |
10/2021 | GenEp | Seed Round | 0 |
10/2021 | GenEp | Seed Round | 0 |
9/2021 | NANOCHON | Seed Round | 0 |
1/2021 | Mission Secure | Series B | 0 |
1/2021 | Slate Bio | Seed Round | 0 |
8/2020 | BrightSpec | Series B | - |
7/2019 | Merand Pharmaceuticals | Seed Round | - |
6/2019 | Direct Spinal Therapeutics | Venture Round | - |
5/2019 | Arrive Health (formerly RxRevu) | Series A | 0 |
10/2018 | Mission Secure | Series A | 0 |
5/2018 | 510 Kardiac Devices | Seed Round | - |
Name | Price |
---|
Name | Size | Announced Date |
---|